← Comparing 1 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
O-GlcNAcylation at T212 competes with phosphorylation to red (OGT) — 0.00 AD fine-mapping identifies causal variants in microglia-spec (TREM2) — 0.00 Heparan sulfate proteoglycan binding selectivity determines (SDC3 (Syndecan-3)) — 0.00 XOR+ stress-responsive astrocytes represent a novel AD-assoc (XOR) — 0.00 Projection-specific vulnerability to complement-mediated syn (C1QA) — 0.00 Convergent NF-κB enhancers across diverse priming stimuli sh (BRD4) — 0.00 Rare TREM2-TYROBP pathway variants complement standard PRS b (PLCG2) — 0.00 Gut-derived butyrate reprograms microglia for amyloid cleara (HDAC2) — 0.00 Glucosylceramide accumulation nucleates alpha-synuclein aggr (GBA) — 0.00 NAD+-SIRT1-H3K9me3 restoration enables true senescence rever (SIRT1) — 0.00 Tissue-specific interactome destabilization drives phenotype (%s) — 0.00 H2S/butyrate imbalance drives enteric alpha-synuclein pathol (SNCA) — 0.00 Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.95 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.94 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.93 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.92 CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli (CYP46A1) — 0.92 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 Selective Acid Sphingomyelinase Modulation Therapy (SMPD1) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 CYP46A1 Overexpression Gene Therapy (CYP46A1) — 0.92 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 SASP-Mediated Complement Cascade Amplification (C1Q/C3) — 0.91
Add
|
× [Archived Hypothesis]
- · - · mechanistic
Composite 0.300
Price $0.30
Evidence For 0
Evidence Against 0
Radar Chart — 10 Dimensions
Score Breakdown
Dimension [Archived Hypothesis] Mechanistic 0.000 Evidence 0.000 Novelty 0.000 Feasibility 0.000 Impact 0.000 Druggability 0.000 Safety 0.000 Competition 0.000 Data 0.000 Reproducible 0.000 KG Connect 0.500
Evidence [Archived Hypothesis] No evidence citations yet
Debate Excerpts [Archived Hypothesis] 4 rounds · quality: 0.81
Theorist # Legacy Pre-Pipeline Hypotheses: Neurodegeneration
---
## Hypothesis 1: Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disease
**Mechanism:** Misfolded α-synuclein (aSy...
Skeptic # Critical Evaluation of Legacy Pre-Pipeline Hypotheses
## General Methodological Concerns (Cross-Cutting Issues)
Before evaluating individual hypotheses, several systemic weaknesses affect the enti...
Domain Expert # Comprehensive Feasibility Assessment: Legacy Neurodegeneration Hypotheses
## Preamble
This assessment evaluates each hypothesis across five critical domains using a standardized framework. Evidenc...
Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease",
"description": "TREM2 loss-of-function variants ...
Price History Overlay